Technical Analysis for EVO - Evotec SE
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 7.65 | 3.94% | 0.29 |
EVO closed up 3.94 percent on Tuesday, April 23, 2024, on 72 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Apr 24
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 3.94% | |
| 50 DMA Resistance | Bearish | 3.94% | |
| Doji - Bearish? | Reversal | 3.94% | |
| Gapped Up | Strength | 3.94% | |
| Oversold Stochastic | Weakness | 3.94% | |
| Stochastic Buy Signal | Bullish | 8.20% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 8 hours ago |
| Gapped Up (Full) | about 11 hours ago |
| Rose Above 20 DMA | about 11 hours ago |
| Rose Above Previous Day's High | about 11 hours ago |
| Rose Above 50 DMA | about 11 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/24/2024
Evotec is an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry. Evotec's mission is to discover best and first-in-class medicines for a broad range of difficult to treat diseases in collaboration with our partners. Evotec has built a comprehensive suite of fully integrated, next generation technology platforms which it believes will transform the way new drugs are discovered. By leveraging the advanced capabilities of Evotec's integrated platforms, Evotec is able to provide solutions to its partners that enable significant improvements in the quality of new drugs while accelerating the drug discovery process and reducing the high cost of attrition often associated with traditional drug discovery processes.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Disease Health Sciences Drugs Natural Sciences Medication Drug Discovery Evotec
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Disease Health Sciences Drugs Natural Sciences Medication Drug Discovery Evotec
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.4924 |
| 52 Week Low | 6.8339 |
| Average Volume | 47,077 |
| 200-Day Moving Average | 9.60 |
| 50-Day Moving Average | 7.37 |
| 20-Day Moving Average | 7.46 |
| 10-Day Moving Average | 7.24 |
| Average True Range | 0.27 |
| RSI (14) | 55.56 |
| ADX | 16.32 |
| +DI | 35.28 |
| -DI | 24.13 |
| Chandelier Exit (Long, 3 ATRs) | 7.16 |
| Chandelier Exit (Short, 3 ATRs) | 7.80 |
| Upper Bollinger Bands | 8.00 |
| Lower Bollinger Band | 6.92 |
| Percent B (%b) | 0.67 |
| BandWidth | 14.54 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0054 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.95 | ||||
| Resistance 3 (R3) | 7.96 | 7.86 | 7.90 | ||
| Resistance 2 (R2) | 7.86 | 7.79 | 7.86 | 7.88 | |
| Resistance 1 (R1) | 7.76 | 7.74 | 7.81 | 7.75 | 7.87 |
| Pivot Point | 7.66 | 7.66 | 7.69 | 7.66 | 7.66 |
| Support 1 (S1) | 7.56 | 7.59 | 7.61 | 7.55 | 7.43 |
| Support 2 (S2) | 7.46 | 7.54 | 7.46 | 7.42 | |
| Support 3 (S3) | 7.36 | 7.46 | 7.40 | ||
| Support 4 (S4) | 7.35 |
